wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q24633710-169346E0-D4DD-4BAA-913F-1D09DF62E995
Q24633710-169346E0-D4DD-4BAA-913F-1D09DF62E995
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24633710-169346E0-D4DD-4BAA-913F-1D09DF62E995
Update on the rational use of Y-ibritumomab tiuxetan in the treatment of follicular lymphoma
P2860
Q24633710-169346E0-D4DD-4BAA-913F-1D09DF62E995
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24633710-169346E0-D4DD-4BAA-913F-1D09DF62E995
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
927e1fc086e6fc01168ba40d05c1d7b5b252669b
P2860
Subsequent chemotherapy regimens are well tolerated after radioimmunotherapy with yttrium-90 ibritumomab tiuxetan for non-Hodgkin's lymphoma.